Wei XIA, PhD
13
2
3
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 13 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Using Mukbang to Improve Appetite, Nutritional Status and Quality of Life in Children With Cancer
Role: lead
The Correlation Between Sleep Quality and Sleep Aid Use and Dietary Patterns
Role: lead
Correlation of Dry Eye Disease, Problematic Smartphone Use and Sleep Quality in Adolescents and Young Adults
Role: lead
Development and Improvement of Home Rehabilitation Scheme for Preschool Children With Congenital Heart Disease After Operation
Role: lead
Construction of a Risk Screening Tool for New Psychoactive Substance Misuse Among Adolescents and Young Adults
Role: lead
Effect of Health Diary on Self-management in Adolescent Patients With Fixed Orthodontic Appliance
Role: lead
Treatment Adherence And Influencing Factors in Children With Helicobacter Pylori Infection During Eradication Therapy
Role: lead
Correlation Study of Family Communication Disorders and Negative Network Use Behavior Among Adolescents
Role: lead
An Internet-Based Intervention With Peer Support for the Mental Health of Youths
Role: lead
Research on the Influence of Mukbang on Brain Activation in Children With Cancer Based on fMRI
Role: lead
Construction of Early Warning Model for the New Psychoactive Substances Using in Adolescents
Role: lead
The Changes of Coping With Stressful Events Among Adolescents Under the COVID-19 Pandemic.
Role: lead
Influencing Factors and Their Approach of Kinesiophobia in Patients With Traumatic Fractures
Role: lead
All 13 trials loaded